Delivery Order SPE2DB24D1205-SPE2DB25FDARA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,408.77 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on May 30, 2025, with completion targeted for June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,609.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units) with a ceiling value of $3,199.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.12 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price and an ultimate completion date of September 17, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,710.84 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.12 to AmerisourceBergen Drug Corp for Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,858.83 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count unit). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competitively awarded. This delivery order is issued...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDARADelivery Order
The Defense Logistics Agency awarded a $15,451.82 delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with performance in Conshohocken, Pennsylvania. The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to furnish pharmaceutical products and medical supplies globally in support of military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA IDC encompasses a wide range of pharmaceutical products including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for esomeprazole, a proton pump inhibitor commonly used for gastrointestinal acid reflux management, represents a routine pharmaceutical resupply component of the company's broader mission to support Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/18/25 |